Summary of all the Indicators
Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Innate Pharma’s (IDDA) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Innate Pharma is a Buy.
Innate Pharma’s (IDDA) 20-Day exponential moving average is 1.38, while Innate Pharma’s (IDDA) share price is €1.73, making it a Sell.
Innate Pharma’s (IDDA) 50-Day exponential moving average is 1.49, while Innate Pharma’s (IDDA) share price is €1.73, making it a Sell.
Innate Pharma (IDDA) Pivot Points
Classic
1.12
1.16
1.22
1.26
1.32
1.36
1.42
Fibonacci
1.16
1.19
1.22
1.26
1.29
1.32
1.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Innate Pharma (IDDA) Moving Averages
MA5
1.25Buy
1.28Buy
MA10
1.28Buy
1.30Sell
MA20
1.40Sell
1.38Sell
MA50
1.59Sell
1.49Sell
MA100
1.53Sell
1.50Sell
MA200
1.43Sell
1.49Sell
Innate Pharma’s (IDDA) 10-Day exponential moving average is 1.30, while Innate Pharma’s (IDDA) share price is €1.73, making it a Sell.
Innate Pharma’s (IDDA) 100-Day exponential moving average is 1.50, while Innate Pharma’s (IDDA) share price is €1.73, making it a Sell.
Innate Pharma’s (IDDA) stock price is €1.73 and Innate Pharma’s (IDDA) 50-day simple moving average is 1.59, creating a Sell signal.
Innate Pharma’s (IDDA) stock price is €1.73 and Innate Pharma’s (IDDA) 100-day simple moving average is 1.53, creating a Sell signal.
Innate Pharma’s (IDDA) stock price is €1.73 and Innate Pharma’s (IDDA) 200-day simple moving average is 1.43, creating a Sell signal.
Innate Pharma (IDDA) Technical Indicators
RSI (14)
42.40
Neutral
STOCH (9,6)
57.07
Neutral
STOCHRSI (14)
36.02
Neutral
MACD (12,26)
-0.10
Buy
ADX (14)
13.49
Buy
Williams %R
-63.64
Buy
CCI (14)
-73.39
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
62.97
Neutral
ROC
-16.88
Sell
Innate Pharma’s (IDDA) Relative Strength Index (RSI) is 42.40, creating a Neutral signal.
Innate Pharma’s (IDDA) Trend Strength Indicator (ADX) is 13.49, creating a Buy signal.
Innate Pharma’s (IDDA) Commodity Channel Index (CCI) is -73.39, creating a Neutral signal.
Innate Pharma’s (IDDA) Price Rate of Change (ROC) is -16.88, creating a Sell signal.
FAQ
Is IDDA a Buy, Hold, or Sell?
Based on IDDA’s technical indicators, IDDA is a Sell.
What is IDDA’s RSI (14)?
IDDA’s RSI (14) is 42.40, which suggests IDDA is a Neutral.
What is IDDA’s MACD?
IDDA’s MACD is -0.10, which suggests IDDA is a Buy.
What is IDDA’s 5-day moving average?
IDDA’s 5-day moving average is 1.25, which suggests IDDA is a Buy.
What is IDDA’s 20-day moving average?
IDDA 20-day moving average is 1.40, which suggests IDDA is a Sell.
What is IDDA’s 50-day moving average?
IDDA’s 50-day moving average is 1.59, which suggests IDDA is a Sell.
What is IDDA’s 200-day moving average?
IDDA’s 200-day moving average is 1.43, which suggests IDDA is a Sell.
What is IDDA’s Williams % R (14)?
IDDA’s Williams % R (14) is -63.64, which suggests IDDA is a Buy.
What is IDDA’s CCI (14)?
IDDA’s CCI (14) is -73.39, which suggests IDDA is a Neutral.
What is the share price of Innate Pharma?
Innate Pharma's share price is N/A€.